120 related articles for article (PubMed ID: 29515595)
1. Targeted Delivery of
Lakhrif Z; Moreau A; Hérault B; Di-Tommaso A; Juste M; Moiré N; Dimier-Poisson I; Mévélec MN; Aubrey N
Front Immunol; 2018; 9():317. PubMed ID: 29515595
[TBL] [Abstract][Full Text] [Related]
2. Yeast Shells Encapsulating Adjuvant AS04 as an Antigen Delivery System for a Novel Vaccine against
Zhu L; Lei Z; Xia X; Zhang Y; Chen Y; Wang B; Li J; Li G; Yang G; Cao G; Yin Z
ACS Appl Mater Interfaces; 2021 Sep; 13(34):40415-40428. PubMed ID: 34470103
[No Abstract] [Full Text] [Related]
3. Specific Cell Targeting by
Aljieli M; Rivière C; Lantier L; Moiré N; Lakhrif Z; Boussemart AF; Cnudde T; Lajoie L; Aubrey N; Ahmed EM; Dimier-Poisson I; Di-Tommaso A; Mévélec MN
Cells; 2024 Jun; 13(11):. PubMed ID: 38891106
[No Abstract] [Full Text] [Related]
4. Parasite Carbohydrate Vaccines.
Jaurigue JA; Seeberger PH
Front Cell Infect Microbiol; 2017; 7():248. PubMed ID: 28660174
[TBL] [Abstract][Full Text] [Related]
5. Recent progress in vaccine development targeting pre-clinical human toxoplasmosis.
Chu KB; Quan FS
Parasites Hosts Dis; 2023 Aug; 61(3):231-239. PubMed ID: 37648228
[TBL] [Abstract][Full Text] [Related]
6. Enhancing the detection of
Hannachi E; Bouratbine A; Mousli M
Biotechnol Rep (Amst); 2019 Sep; 23():e00360. PubMed ID: 31341791
[TBL] [Abstract][Full Text] [Related]
7. Convergent Met and voltage-gated Ca
Ólafsson EB; Ten Hoeve AL; Li-Wang X; Westermark L; Varas-Godoy M; Barragan A
J Cell Sci; 2020 Apr; 134(5):. PubMed ID: 32161101
[TBL] [Abstract][Full Text] [Related]
8. Enhanced Vaccine Immunogenicity Enabled by Targeted Cytosolic Delivery of Tumor Antigens into Dendritic Cells.
Truex NL; Rondon A; Rössler SL; Hanna CC; Cho Y; Wang BY; Backlund CM; Lutz EA; Irvine DJ; Pentelute BL
ACS Cent Sci; 2023 Sep; 9(9):1835-1845. PubMed ID: 37780364
[TBL] [Abstract][Full Text] [Related]
9. Multi-Omics Studies Demonstrate
Hargrave KE; Woods S; Millington O; Chalmers S; Westrop GD; Roberts CW
Front Cell Infect Microbiol; 2019; 9():309. PubMed ID: 31572687
[No Abstract] [Full Text] [Related]
10. Induction of Th1 type-oriented humoral response through intranasal immunization of mice with SAG1-Toxoplasma gondii polymeric nanospheres.
Naeem H; Sana M; Islam S; Khan M; Riaz F; Zafar Z; Akbar H; Shehzad W; Rashid I
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1025-1034. PubMed ID: 29873522
[TBL] [Abstract][Full Text] [Related]
11. Engineering and Functional Evaluation of Neutralizing Antibody Fragments Against Congenital Toxoplasmosis.
di Tommaso A; Juste MO; Lakhrif Z; Mévélec MN; Borowczyk C; Hammeni P; Désoubeaux G; Van Langendonck N; Debierre-Grockiego F; Aubrey N; Dimier-Poisson I
J Infect Dis; 2021 Aug; 224(4):705-714. PubMed ID: 33728452
[TBL] [Abstract][Full Text] [Related]
12. Recombinant antigen delivery to dendritic cells as a way to improve vaccine design.
de Souza-Silva GA; Sulczewski FB; Boscardin SB
Exp Biol Med (Maywood); 2023 Oct; 248(19):1616-1623. PubMed ID: 37750021
[TBL] [Abstract][Full Text] [Related]
13. Heterologous DNA Prime- Subunit Protein Boost with Chikungunya Virus E2 Induces Neutralizing Antibodies and Cellular-Mediated Immunity.
Coirada FC; Fernandes ER; Mello LR; Schuch V; Soares Campos G; Braconi CT; Boscardin SB; Santoro Rosa D
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445695
[TBL] [Abstract][Full Text] [Related]
14. A Lower Dose of Infection Generates a Better Long-Term Immune Response against Toxoplasma gondii.
Moretto MM; Chen J; Meador M; Phan J; Khan IA
Immunohorizons; 2023 Feb; 7(2):177-190. PubMed ID: 36883950
[TBL] [Abstract][Full Text] [Related]
15. Modulation of autophagy as a therapeutic strategy for
Cheng A; Zhang H; Chen B; Zheng S; Wang H; Shi Y; You S; Li M; Jiang L
Front Cell Infect Microbiol; 2022; 12():902428. PubMed ID: 36093185
[No Abstract] [Full Text] [Related]
16. Nano Drug Delivery System for Tumor Immunotherapy: Next-Generation Therapeutics.
Zhou L; Zou M; Xu Y; Lin P; Lei C; Xia X
Front Oncol; 2022; 12():864301. PubMed ID: 35664731
[TBL] [Abstract][Full Text] [Related]
17. Targeted Delivery of Nanovaccine to Dendritic Cells via DC-Binding Peptides Induces Potent Antiviral Immunity in vivo.
Lu Y; Liu ZH; Li YX; Xu HL; Fang WH; He F
Int J Nanomedicine; 2022; 17():1593-1608. PubMed ID: 35411142
[TBL] [Abstract][Full Text] [Related]
18. STxB as an Antigen Delivery Tool for Mucosal Vaccination.
Tartour E; Johannes L
Toxins (Basel); 2022 Mar; 14(3):. PubMed ID: 35324699
[TBL] [Abstract][Full Text] [Related]
19. PLGA Nanoparticles as an Efficient Platform in Protein Vaccines Against Toxoplasma gondii.
Allahyari M
Acta Parasitol; 2022 Jun; 67(2):582-591. PubMed ID: 35013939
[TBL] [Abstract][Full Text] [Related]
20. With Chitosan and PLGA as the Delivery Vehicle,
Yu Z; Cao W; Gao X; Aleem MT; Liu J; Luo J; Yan R; Xu L; Song X; Li X
Front Immunol; 2021; 12():726615. PubMed ID: 34512659
[No Abstract] [Full Text] [Related]
[Next] [New Search]
